These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 3568034)

  • 1. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
    Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
    Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
    Fujita M; Taguchi T; Nakano Y; Oota J; Kimoto Y; Kumanishi Y; Oomichi M; Usugane M; Ueda N; Tsukahara Y
    Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mass screening for colorectal cancer--issues and future prospects].
    Kobayashi S
    Gan No Rinsho; 1984 May; 30(6 Suppl):611-5. PubMed ID: 6748232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of fecal occult blood screening in automated multiphasic health testing and services.
    Nishikawa A; Okuda T; Kubota I; Azuma H; Tanaka T; Koyasu T; Kumazaki N; Iwata H; Tanaka T; Kato K
    Jpn J Clin Oncol; 1987 Jun; 17(2):107-12. PubMed ID: 3613137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
    Yu H
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for cancer of the large intestine].
    Gnauck R
    Wien Med Wochenschr; 1988 Jun; 138(11-12):257-60. PubMed ID: 3051684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for colorectal carcinoma in AMHTS (automated multiphasic health testing and services)].
    Kikkawa N; Sasai H; Murai M; Mizuno S; Miyagawa S; Furota A
    Gan No Rinsho; 1983 Nov; 29(14):1644-6. PubMed ID: 6663710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of a cancer registry in a mass screening program for colorectal cancer.
    Michalek AM; Cummings KM; Gamble D
    Cancer Detect Prev; 1988; 11(3-6):353-7. PubMed ID: 3390856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of screening for colorectal cancer.
    Crespi M; Casale V; Grassi A; Caperle M; Casale G; Conti E
    Endoscopy; 1981 Sep; 13(5):203-6. PubMed ID: 7274170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
    Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
    Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult-blood screening for colorectal carcinoma: the risks.
    Frank JW
    Am J Prev Med; 1985; 1(4):25-32. PubMed ID: 3870908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].
    Li S; Zhang C; Xu E
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):381-3. PubMed ID: 8697982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adapted program of colorectal cancer screening--7 years experience and cost-benefit analysis.
    Fric P; Zavoral M; Dvoráková H; Zoubek V; Roth Z
    Hepatogastroenterology; 1994 Oct; 41(5):413-6. PubMed ID: 7851847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening in average risk individuals.
    Huang CS; Lal SK; Farraye FA
    Cancer Causes Control; 2005 Mar; 16(2):171-88. PubMed ID: 15868457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for colo-rectal neoplasms by the study of fecal occult blood].
    Castiglione G; Pacini F; Maltoni G
    Quad Sclavo Diagn; 1984 Dec; 20(4):440-50. PubMed ID: 6537553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood in feces. A screening method for early discovery of colorectal cancer].
    Kewenter J
    Lakartidningen; 1994 Mar; 91(9):803-4. PubMed ID: 8139343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.